bioRxivCancer BiologyPreprint
Exploiting Homeostatic Repopulation to Increase DC Vaccine Efficacy in Multiple Myeloma
Chandler D. Gatenbee, Núria Folguera-Blasco, Charlie Daneils, Jill Gallaher, Russell C. RockneiD, Casey Adams, Michael Nicholson, Eleni Maniati, John Kennedy, Kimberly Luddy, Frederick L. Locke, Mark Robertson-Tessi
Abstract
Standard of care for multiple myeloma involves autologous hematopoietic cell transplant (AHCT), which can extend life by a year; however the disease remains incurable. A dendritic cell vaccine developed at Moffitt will be used both immediately before and after AHCT, with the aim of achieving complete response. Data will be collected during the trial to test the biological activity of the vaccine. This data will parameterize a model that facilitates the exploration of outcomes when varying the timing of vaccination. This calibrated model will also inform the design of a follow-up trial, which will include vaccination in conjunction with other immunotherapies.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Myeloma and therapy reshape the bone marrow niche to durably constrain immune reconstitution and vaccine responsiveness
Aishwarya Chander, Samir Rachid Zaim, … Melinda L. Angus-Hill·bioRxiv·Apr 9, 2026
- TriLeukeVax: A CD80/IL-15/IL-15Rα Expressing Autologous AML Cell Vaccine Elicits Robust Anti-Leukemic Cytolytic Activity
Jacob Du, Uthpala N. Wijayaratna, … Karin M. L. Gaensler·bioRxiv·Nov 7, 2025
- Immature dendritic cells promote high avidity tuning of vaccine T cell response
A. Kumbhari, C. A. Egelston, … P. S. Kim·bioRxiv·Jul 16, 2020
- Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation
C. Tripodo, B. Bassani, … S. Sangaletti·bioRxiv·May 19, 2021
- Multiple myeloma long-term survivors display sustained immune alterations decades after first line therapy
R. Lutz, F. Gruenschlaeger, … S. Haas·bioRxiv·May 27, 2023
- Longitudinal multi-omic profiling uncovers immune escape and predictors of response in multiple myeloma
Denis J. Ohlstrom, William Pilcher, … Manoj Bhasin·bioRxiv·May 27, 2025